Exendin (9-39) Acetate 10 mg/vial (Clinalfa basic)

U-1160

A considerable number of publications on Clinalfa products used in clinical trials are available. The most important publications are listed below. For a comprehensive list please contact us.

 

All information is compiled to the best of our knowledge. We cannot be made liable for any possible errors or misprints.

Clinalfa

Literature references citing the Clinalfa basic product

 2014

Melhorn, S. J., Tyagi, V., Smeraglio, A., Roth, C. L. and Schur, E. A.
Initial evidence that GLP-1 receptor blockade fails to suppress postprandial satiety or promote food intake in humans.
Appetite 82, 85-90 (2014)
Abstract

Steinert, R. E., Schirra, J., Meyer-Gerspach, A. C., Kienle, P., Fischer, H., Schulte, F., Goeke, B. and Beglinger, C.
Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men.
Am. J. Clin. Nutr. 100, 514-523 (2014)
Abstract

van Bloemendaal, L., RG, I. J., Ten Kulve, J. S., Barkhof, F., Konrad, R. J., Drent, M. L., Veltman, D. J. and Diamant, M.
GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.
Diabetes 63, 4186-4196 (2014)
Abstract

 

 2012

Woerle, H. J., Carneiro, L., Derani, A., Goke, B. and Schirra, J.
The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes.
Diabetes 61, 2349-2358 (2012)
Abstract

 

 2010

Salehi, M., Aulinger, B., Prigeon, R. L. and D'Alessio, D. A.
Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes.
Diabetes 59, 1330-1337 (2010)
Abstract

Witte, A. B., Gryback, P., Jacobsson, H., Naslund, E., Hellstrom, P. M., Holst, J. J., Hilsted, L. and Schmidt, P. T.
Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion.
Scand. J. Gastroenterol. 46, 428-435 (2010)
Abstract

 

 2009

Schirra, J., Nicolaus, M., Woerle, H. J., Struckmeier, C., Katschinski, M. and Goke, B.
GLP-1 regulates gastroduodenal motility involving cholinergic pathways.
Neurogastroenterol. Motil. 21, 609-618, e21-22 (2009)
Abstract

 

 2008

Salehi, M., Vahl, T. P. and D'Alessio, D. A.
Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion.
J. Clin. Endocrinol. Metab. 93, 4909-4916 (2008)
Abstract

 

 2006

Schirra, J., Nicolaus, M., Roggel, R., Katschinski, M., Storr, M., Woerle, H. J. and Goke, B.
Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.
Gut 55, 243-251 (2006)
Abstract

 

Literature references citing the active pharmaceutical ingredient (API)

2011

Nicolaus, M., Brodl, J., Linke, R., Woerle, H. J., Goke, B. and Schirra, J.
Endogenous GLP-1 regulates postprandial glycemia in humans: relative contributions of insulin, glucagon, and gastric emptying.
J. Clin. Endocrinol. Metab. 96, 229-236 (2011)
Abstract